high-risk merchant account for CBD and nutra

CBD, Nutra & Supplements — high-risk bank and merchant account opening.

CBD and nutra are classified high-risk by every major acquirer due to claim-substantiation rules, subscription billing models and elevated chargeback ratios. We open registered high-risk MIDs and operating banking that won't churn after the first reserve review.

Why mainstream banks decline

The classification problem.

  • Claim-substantiation flags by Visa / Mastercard compliance
  • Free-trial and continuity billing models attract elevated chargeback ratios
  • Cannabinoid SKU mix declined wholesale by mainstream acquirers
What we actually open

The high-risk banking and acquiring stack.

High-risk nutra MIDs

Registered specialist acquirers with realistic reserve and rolling-reserve terms.

CBD-specific acquiring

Hemp-derived CBD MIDs with lab-report and claims-review compliance built in.

Subscription billing platform

Continuity billing with chargeback tooling, decline-recovery and PCI scope contained.

Operating bank

Corporate banking at an institution that accepts the SKU mix.

Live coverage

Jurisdictions we open accounts across

UKEUUSA (specific states)Canada
FAQ

What operators ask before committing.

Why is CBD high-risk even where it's legal?

Schemes treat hemp-derived CBD as a specialty vertical with bespoke approval, regardless of national legality. Specialist acquirers handle the approval; mainstream ones decline.

Talk to a partner

Honest probability, in writing, before you commit fees.

A confidential 30-minute call. We map the vertical, the flow and the jurisdictions in play, then send a written read on which institutions are bankable for you this quarter.